Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) EPS (Basic): 2020-2024

Historic EPS (Basic) for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$0.72.

  • Journey Medical's EPS (Basic) rose 25.00% to -$0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 62.77%. This contributed to the annual value of -$0.72 for FY2024, which is 242.86% down from last year.
  • Journey Medical's EPS (Basic) amounted to -$0.72 in FY2024, which was down 242.86% from -$0.21 recorded in FY2023.
  • In the past 5 years, Journey Medical's EPS (Basic) registered a high of $0.58 during FY2020, and its lowest value of -$4.32 during FY2021.
  • Its 3-year average for EPS (Basic) is -$0.87, with a median of -$0.72 in 2024.
  • Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 844.83% in 2021, then soared by 87.57% in 2023.
  • Over the past 5 years, Journey Medical's EPS (Basic) (Yearly) stood at $0.58 in 2020, then tumbled by 844.83% to -$4.32 in 2021, then skyrocketed by 60.88% to -$1.69 in 2022, then skyrocketed by 87.57% to -$0.21 in 2023, then crashed by 242.86% to -$0.72 in 2024.